Quantitative EEG During PSG in Patients With and Without Fibromyalgia
FMQEEG-10-26
1 other identifier
observational
560
1 country
1
Brief Summary
The purpose of this study is to retrospectively analyze Clinical and Nocturnal Polysomnographic Data (Overnight Sleep Studies) in patients with and without Fibromyalgia. Fibromyalgia is a pain syndrome associated with dysfunctional sleep, fatigue, frequent awakenings, non-refreshing sleep, and alpha frequency intrusions. Quantitative EEG during routine Nocturnal Polysomnography can be used to assess Alpha/Delta sleep. Hypothesis: Alpha intrusions may be an objective marker for Fibromyalgia and may correlate with current clinical American College of Rheumatology Criteria for the diagnosis of Fibromyalgia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
September 10, 2010
CompletedFirst Posted
Study publicly available on registry
August 28, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2012
CompletedOctober 13, 2016
October 1, 2016
2.3 years
September 10, 2010
October 12, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Delta Event/Alpha Event Ratios in Non-REM sleep
Assess the sensitivity and specificity of Delta Event/Alpha Event Ratios in Non-REM sleep in patients with and without Fibromyalgia
up to 24 weeks
Study Arms (2)
ACR diagnosis of Fibromyalgia
Patients without Fibromyalgia
Eligibility Criteria
Private Sleep Practice
You may qualify if:
- Completed a polysomnogram
- Complaints of disordered sleep
- Age 18 to 80 inclusive
- Men and women
You may not qualify if:
- History of seizure
- use of benzodiazepines
- use of AEDs
- any significant medical condition other than disorder sleep or fibromyalgia that would influence qEEG measures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
SouthCoast Medical Group
Savannah, Georgia, 31406, United States
Related Publications (1)
Rosenfeld VW, Rutledge DN, Stern JM. Polysomnography with quantitative EEG in patients with and without fibromyalgia. J Clin Neurophysiol. 2015 Apr;32(2):164-70. doi: 10.1097/WNP.0000000000000134.
PMID: 25233248DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Victor Rosenfeld, MD
SouthCoast Medical Group
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 10, 2010
First Posted
August 28, 2012
Study Start
July 1, 2010
Primary Completion
October 1, 2012
Study Completion
October 1, 2012
Last Updated
October 13, 2016
Record last verified: 2016-10